UiPath (NYSE:PATH) Downgraded to Buy Rating by Wall Street Zen

UiPath (NYSE:PATHGet Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

PATH has been the subject of several other research reports. Mizuho decreased their price target on UiPath from $15.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, March 12th. Canaccord Genuity Group reduced their price objective on shares of UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, March 12th. Evercore increased their target price on shares of UiPath from $15.00 to $17.00 and gave the company an “in-line” rating in a research report on Thursday, December 4th. Bank of America lowered their target price on shares of UiPath from $14.00 to $12.00 and set an “underperform” rating on the stock in a research note on Thursday, March 12th. Finally, Needham & Company LLC upgraded shares of UiPath from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $14.07.

Check Out Our Latest Stock Analysis on PATH

UiPath Trading Down 3.1%

PATH opened at $10.70 on Friday. The business’s 50 day moving average is $12.05 and its 200-day moving average is $14.01. The stock has a market cap of $5.72 billion, a PE ratio of 20.58, a price-to-earnings-growth ratio of 1.81 and a beta of 1.09. UiPath has a twelve month low of $9.38 and a twelve month high of $19.84.

UiPath (NYSE:PATHGet Free Report) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.05. UiPath had a return on equity of 5.69% and a net margin of 17.53%.The business had revenue of $481.11 million during the quarter, compared to analyst estimates of $464.81 million. During the same period in the prior year, the company posted $0.26 EPS. The business’s revenue for the quarter was up 13.4% compared to the same quarter last year. As a group, analysts forecast that UiPath will post -0.17 EPS for the current year.

Insider Buying and Selling at UiPath

In related news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Monday, January 26th. The stock was sold at an average price of $15.01, for a total transaction of $675,450.00. Following the transaction, the chief executive officer directly owned 27,893,585 shares of the company’s stock, valued at $418,682,710.85. The trade was a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ashim Gupta sold 67,468 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the completion of the sale, the chief financial officer owned 557,028 shares in the company, valued at approximately $8,968,150.80. This trade represents a 10.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 517,468 shares of company stock valued at $8,372,185. Insiders own 23.19% of the company’s stock.

Hedge Funds Weigh In On UiPath

Several large investors have recently made changes to their positions in the business. Royal Bank of Canada lifted its stake in UiPath by 8.4% during the first quarter. Royal Bank of Canada now owns 140,774 shares of the company’s stock valued at $1,450,000 after purchasing an additional 10,872 shares during the last quarter. Woodline Partners LP grew its position in UiPath by 69.6% in the first quarter. Woodline Partners LP now owns 22,566 shares of the company’s stock worth $232,000 after buying an additional 9,257 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in UiPath by 5.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,477,730 shares of the company’s stock worth $15,221,000 after buying an additional 75,737 shares during the last quarter. Sivia Capital Partners LLC bought a new position in shares of UiPath in the second quarter valued at $169,000. Finally, Creative Planning increased its holdings in shares of UiPath by 11.7% in the second quarter. Creative Planning now owns 80,623 shares of the company’s stock valued at $1,032,000 after buying an additional 8,460 shares in the last quarter. Institutional investors own 62.50% of the company’s stock.

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

See Also

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.